Obsessive compulsive disorder in Huntington disease:: A case of isolated obsessions successfully treated with sertraline

被引:26
作者
Patzold, T
Brüne, M
机构
[1] Ruhr Univ Bochum, Dept Neurol, D-44789 Bochum, Germany
[2] Ruhr Univ Bochum, Dept Psychiat, D-44789 Bochum, Germany
[3] Ruhr Univ Bochum, Dept Psychotherapy, D-44789 Bochum, Germany
来源
NEUROPSYCHIATRY NEUROPSYCHOLOGY AND BEHAVIORAL NEUROLOGY | 2002年 / 15卷 / 03期
关键词
Huntington disease; obsessive compulsive disorder; sertraline;
D O I
10.1097/01.WNN.0000020011.79870.8A
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Objective: To report about a patient with Huntington disease (HD) in combination with obsessions who was successfully treated with a selective serotonin reuptake inhibitor. Background: Obsessive compulsive disorder (OCD) has rarely been reported in association with HD, and little is known about the treatment of patients with OCD symptoms and HD. Methods: We describe a 42-year-old woman who experienced isolated obsessive thoughts about killing her neighbor 10 years after the onset of her genetically confirmed HD. Results: Sertraline was prescribed at a daily dose of 150 mg with a complete remission of obsessive ideas within 4 weeks of treatment. Conclusions: The basal ganglia are known to play an important role in the pathogenesis of OCD and HD. Thus, it is conceivable that a degeneration of the caudate nucleus as in HD may also account for obsessive and compulsive symptoms in this disorder. To our knowledge, this is the first report about a patient with HD in combination With obsessions alone who was successfully treated with a selective serotonin reuptake inhibitor. However, the association of OCD with HD warrants further systematic evaluation.
引用
收藏
页码:216 / 219
页数:4
相关论文
共 14 条
[1]   PARALLEL ORGANIZATION OF FUNCTIONALLY SEGREGATED CIRCUITS LINKING BASAL GANGLIA AND CORTEX [J].
ALEXANDER, GE ;
DELONG, MR ;
STRICK, PL .
ANNUAL REVIEW OF NEUROSCIENCE, 1986, 9 :357-381
[2]   THE RELATIONSHIP BETWEEN TRINUCLEOTIDE (CAG) REPEAT LENGTH AND CLINICAL-FEATURES OF HUNTINGTONS-DISEASE [J].
ANDREW, SE ;
GOLDBERG, YP ;
KREMER, B ;
TELENIUS, H ;
THEILMANN, J ;
ADAM, S ;
STARR, E ;
SQUITIERI, F ;
LIN, BY ;
KALCHMAN, MA ;
GRAHAM, RK ;
HAYDEN, MR .
NATURE GENETICS, 1993, 4 (04) :398-403
[3]  
BAXTER LR, 1987, ARCH GEN PSYCHIAT, V44, P211
[4]   OBSESSIVE-COMPULSIVE DISORDER IN HUNTINGTONS-DISEASE [J].
CUMMINGS, JL ;
CUNNINGHAM, K .
BIOLOGICAL PSYCHIATRY, 1992, 31 (03) :263-270
[5]   Fluoxetine in the treatment of Huntington's disease [J].
De Marchi, N ;
Daniele, F ;
Ragone, MA .
PSYCHOPHARMACOLOGY, 2001, 153 (02) :264-266
[6]   Huntington's disease and its association with psychopathology [J].
De Marchi, N ;
Mennella, R .
HARVARD REVIEW OF PSYCHIATRY, 2000, 7 (05) :278-289
[7]  
De Marchi N, 1998, ACTA PSYCHIAT SCAND, V97, P62
[8]  
DEWHURST K, 1969, CONFIN NEUROL, V31, P258
[9]  
Maia A S, 1999, Rev Hosp Clin Fac Med Sao Paulo, V54, P213, DOI 10.1590/S0041-87811999000600008
[10]  
Patel S V, 1996, Ann Clin Psychiatry, V8, P23, DOI 10.3109/10401239609149087